𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ALZHEIMER’S DISEASE AND ACETYLCHOLINESTERASE INHIBITOR AGENTS: A TWO-YEAR LONGITUDINAL STUDY

✍ Scribed by C. FUSCHILLO; E. ASCOLI; G. FRANZESE; F. CAMPANA; C. CELLO; M. GALDI; S. LA PIA; C. CETRANGOLO

Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
54 KB
Volume
38
Category
Article
ISSN
0167-4943

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DELUSIONS AND HALLUCINATIONS IN ALZHEIME
DELUSIONS AND HALLUCINATIONS IN ALZHEIMER'S DISEASE: RESULTS FROM A TWO-YEAR LONGITUDINAL STUDY
✍ M. HAUPT; B. ROMERO; A. KURZ 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

Issues concerning the frequency of psychotic symptoms in Alzheimer's disease and their relation to the degree and decline of cognitive and functional impairment remain controversial. We therefore investigated 78 outpatients with a clinical diagnosis of Alzheimer's disease according to ICD-10 draft r

Factors associated with mortality in pat
Factors associated with mortality in patients with early-onset Alzheimer's disease: a five-year longitudinal study
✍ Akinori Ueki; Hidetaka Shinjo; Hiroko Shimode; Takaya Nakajima; Yoshio Morita 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

To identify neuropsychiatric and somatic factors related to survival in early-onset Alzheimer's disease, we longitudinally studied 108 patients (35 male, 73 female) with early-onset Alzheimer's disease who were 46 to 64 years old at onset and 50 to 69 years old when diagnosed at our institution. A f

A longitudinal study of Alzheimer's dise
A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline
✍ Guk-Hee Suh; Young-Su Ju; Byeong Kil Yeon; Ajit Shah 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## Abstract ## Objective To measure rates of decline in cognition and function in patients with Alzheimer's disease (AD) and to investigate their accelerating risk factors in Korea. ## Methods This study presents longitudinal data on a community‐based sample of 107 patients with AD, followed at

One-year treatment of Alzheimer's diseas
One-year treatment of Alzheimer's disease with acetylcholinesterase inhibitors: improvement on ADAS-cog and TMT A, no change or worsening on other tests
✍ Alina Borkowska; Marzena Ziolkowska-Kochan; Janusz K. Rybakowski 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

The aim of this study was to assess cognitive functioning measured by selected psychometric and neuropsychological tools in patients with Alzheimer's disease (AD) after 1-year treatment with acetylcholinesterase inhibitors. Seventy-six patients (22 male and 54 female) with a mild to moderate stage o